Germany’s healthcare system is facing a severe crisis due to ongoing medication shortages, with the country now struggling to secure basic medical supplies.
Andreas Gassen, chairman of the National Association of Statutory Health Insurance Physicians (KBV), issued a stark warning, declaring, “The medication supply in Germany is currently at the level of a third-world country.”
His comments come as the shortage of saline solution, an essential component for many treatments, begins to cripple medical care nationwide.
Saline solution is vital in hospitals and doctors’ offices, used as a carrier for medications in infusions and other treatments. However, delivery bottlenecks have led to critical shortages, leaving doctors with no choice but to send patients home untreated. “There are currently supply restrictions in doctors’ practices nationwide,” Gassen told Bild. “Doctors have to send patients home because they don’t have saline solution available.”
The shortages were first flagged by pharmacists in September, and the consequences are now becoming dire. Mathias Arnold, vice president of the Pharmacists’ Association ABDA, explained that the global production of saline is concentrated in the hands of a few highly specialized manufacturers, making the supply chain fragile. “If a producer fails, we have a huge problem,” Arnold said.
He called for political reforms to attract more manufacturers into the market and prevent future bottlenecks.
The crisis extends beyond outpatient care. Gerald Gaß, chief executive of the German Hospital Association (DKG), raised similar alarms, noting that hospitals are also facing shortages of saline and infusion solutions.
“Hospitals are currently not receiving the full quantities that they order from manufacturers,” Gaß said. While hospitals are still managing to care for patients, the escalating situation is becoming unsustainable. “This cannot be achieved in the long term if nothing changes,” he warned.
Germany’s federal health ministry has sought to simplify the import process for saline solution in an attempt to alleviate the shortage, but concerns remain over whether these measures will be sufficient to address the wider problem of drug supply chains in Germany.
